APO Research
Talk to an analyst

APO RESEARCH · REPORT

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)

Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect.

Cancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer.

Selected research

Industry Growth & Trends

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Growth and Trends Forecast to 2032

2 January 2026121 pages

Choose your research edition.

Industry ResearchCirculating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect.

Cancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer.

According to APO Research, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market by Company

Janssen

Qiagen

Advanced Cell Diagnostics

ApoCell

Biofluidica

Clearbridge Biomedics

CytoTrack

Celsee

Fluxion

Gilupi

Cynvenio

On-chip

YZY Bio

BioView

Fluidigm

Ikonisys

AdnaGen

IVDiagnostics

Miltenyi Biotec

ScreenCell

Silicon Biosystems

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Segment by Type

CellSearch

Others

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Segment by Application

Breast Cancer Diagnosis and Treatment

Prostate Cancer Diagnosis and Treatment

Colorectal Cancer Diagnosis and Treatment

Lung Cancer Diagnosis and Treatment

Other Cancers Diagnosis and Treatment

Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Region (2021-2026) Table 4. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Region (2027-2032) Table 6. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Type (2021-2026) Table 9. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share Forecasted by Type (2027-2032) Table 11. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Application (2021-2026) Table 24. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share Forecasted by Application (2027-2032) Table 26. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Trends Table 37. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Drivers Table 38. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Opportunities and Challenges Table 39. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Restraints Table 40. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Market Share by Company (2021-2026) Table 42. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Company Headquarters & Area Served Table 44. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Company, Product Type & Application Table 45. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Janssen Company Information Table 49. Janssen Business Overview Table 50. Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 52. Janssen Recent Development Table 53. Qiagen Company Information Table 54. Qiagen Business Overview Table 55. Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 57. Qiagen Recent Development Table 58. Advanced Cell Diagnostics Company Information Table 59. Advanced Cell Diagnostics Business Overview Table 60. Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 62. Advanced Cell Diagnostics Recent Development Table 63. ApoCell Company Information Table 64. ApoCell Business Overview Table 65. ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 67. ApoCell Recent Development Table 68. Biofluidica Company Information Table 69. Biofluidica Business Overview Table 70. Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 72. Biofluidica Recent Development Table 73. Clearbridge Biomedics Company Information Table 74. Clearbridge Biomedics Business Overview Table 75. Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 77. Clearbridge Biomedics Recent Development Table 78. CytoTrack Company Information Table 79. CytoTrack Business Overview Table 80. CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 82. CytoTrack Recent Development Table 83. Celsee Company Information Table 84. Celsee Business Overview Table 85. Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 87. Celsee Recent Development Table 88. Fluxion Company Information Table 89. Fluxion Business Overview Table 90. Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 92. Fluxion Recent Development Table 93. Gilupi Company Information Table 94. Gilupi Business Overview Table 95. Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 97. Gilupi Recent Development Table 98. Cynvenio Company Information Table 99. Cynvenio Business Overview Table 100. Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 102. Cynvenio Recent Development Table 103. On-chip Company Information Table 104. On-chip Business Overview Table 105. On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 107. On-chip Recent Development Table 108. YZY Bio Company Information Table 109. YZY Bio Business Overview Table 110. YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 112. YZY Bio Recent Development Table 113. BioView Company Information Table 114. BioView Business Overview Table 115. BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 117. BioView Recent Development Table 118. Fluidigm Company Information Table 119. Fluidigm Business Overview Table 120. Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 122. Fluidigm Recent Development Table 123. Ikonisys Company Information Table 124. Ikonisys Business Overview Table 125. Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 127. Ikonisys Recent Development Table 128. AdnaGen Company Information Table 129. AdnaGen Business Overview Table 130. AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 132. AdnaGen Recent Development Table 133. IVDiagnostics Company Information Table 134. IVDiagnostics Business Overview Table 135. IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 137. IVDiagnostics Recent Development Table 138. Miltenyi Biotec Company Information Table 139. Miltenyi Biotec Business Overview Table 140. Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 142. Miltenyi Biotec Recent Development Table 143. ScreenCell Company Information Table 144. ScreenCell Business Overview Table 145. ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 147. ScreenCell Recent Development Table 148. Silicon Biosystems Company Information Table 149. Silicon Biosystems Business Overview Table 150. Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio Table 152. Silicon Biosystems Recent Development Table 153. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2021-2026) & (US$ Million) Table 155. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2021-2026) Table 156. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share Forecast by Country (2027-2032) Table 158. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2021-2026) Table 161. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2021-2026) Table 166. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share Forecast by Country (2027-2032) Table 168. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2021-2026) Table 171. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2021-2026) Table 176. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Image Figure 3. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2021-2032) & (US$ Million) Figure 5. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Region: 2025 VS 2032 Figure 6. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Region (2021-2032) Figure 7. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. CellSearch Image Figure 13. Global CellSearch Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Others Image Figure 15. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Type 2025 VS 2032 Figure 18. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Type (2021-2032) Figure 19. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Type (2021-2032) Figure 21. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Type (2021-2032) Figure 23. Breast Cancer Diagnosis and Treatment Image Figure 24. Global Breast Cancer Diagnosis and Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Prostate Cancer Diagnosis and Treatment Image Figure 26. Global Prostate Cancer Diagnosis and Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Colorectal Cancer Diagnosis and Treatment Image Figure 28. Global Colorectal Cancer Diagnosis and Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Lung Cancer Diagnosis and Treatment Image Figure 30. Global Lung Cancer Diagnosis and Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Other Cancers Diagnosis and Treatment Image Figure 32. Global Other Cancers Diagnosis and Treatment Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Application 2025 VS 2032 Figure 35. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Application (2021-2032) Figure 36. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Application (2021-2032) Figure 38. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2021-2032) Figure 45. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2021-2032) Figure 48. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2021-2032) Figure 51. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2021-2032) Figure 54. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • CellSearch
  • Others
Applications
  • Breast Cancer Diagnosis and Treatment
  • Prostate Cancer Diagnosis and Treatment
  • Colorectal Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Other Cancers Diagnosis and Treatment
Companies covered
  • Janssen
  • Qiagen
  • Advanced Cell Diagnostics
  • ApoCell
  • Biofluidica
  • Clearbridge Biomedics
  • CytoTrack
  • Celsee
  • Fluxion
  • Gilupi
  • Cynvenio
  • On-chip
  • YZY Bio
  • BioView
  • Fluidigm
  • Ikonisys
  • AdnaGen
  • IVDiagnostics
  • Miltenyi Biotec
  • ScreenCell
  • Silicon Biosystems

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2021-2032)
  5. 1.4.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2021-2026)
  6. 1.4.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Region (2027-2032)
  7. 1.5 Key Regions Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (2021-2032)
  8. 1.5.1 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (2021-2032)
2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 CellSearch
  3. 2.1.2 Others
  4. 2.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Type
  5. 2.2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions
  9. 2.3.1 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Type (2021-2026)
3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Breast Cancer Diagnosis and Treatment
  3. 3.1.2 Prostate Cancer Diagnosis and Treatment
  4. 3.1.3 Colorectal Cancer Diagnosis and Treatment
  5. 3.1.4 Lung Cancer Diagnosis and Treatment
  6. 3.1.5 Other Cancers Diagnosis and Treatment
  7. 3.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Application
  8. 3.2.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Regions
  12. 3.3.1 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Trends
  2. 4.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Drivers
  3. 4.3 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Opportunities and Challenges
  4. 4.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue (2021-2026)
  2. 5.2 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Company Headquarters & Area Served
  4. 5.4 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Company, Product Type & Application
  5. 5.5 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Janssen
  2. 6.1.1 Janssen Company Information
  3. 6.1.2 Janssen Business Overview
  4. 6.1.3 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  6. 6.1.5 Janssen Recent Developments
  7. 6.2 Qiagen
  8. 6.2.1 Qiagen Company Information
  9. 6.2.2 Qiagen Business Overview
  10. 6.2.3 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  12. 6.2.5 Qiagen Recent Developments
  13. 6.3 Advanced Cell Diagnostics
  14. 6.3.1 Advanced Cell Diagnostics Company Information
  15. 6.3.2 Advanced Cell Diagnostics Business Overview
  16. 6.3.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  18. 6.3.5 Advanced Cell Diagnostics Recent Developments
  19. 6.4 ApoCell
  20. 6.4.1 ApoCell Company Information
  21. 6.4.2 ApoCell Business Overview
  22. 6.4.3 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  24. 6.4.5 ApoCell Recent Developments
  25. 6.5 Biofluidica
  26. 6.5.1 Biofluidica Company Information
  27. 6.5.2 Biofluidica Business Overview
  28. 6.5.3 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  30. 6.5.5 Biofluidica Recent Developments
  31. 6.6 Clearbridge Biomedics
  32. 6.6.1 Clearbridge Biomedics Company Information
  33. 6.6.2 Clearbridge Biomedics Business Overview
  34. 6.6.3 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  36. 6.6.5 Clearbridge Biomedics Recent Developments
  37. 6.7 CytoTrack
  38. 6.7.1 CytoTrack Company Information
  39. 6.7.2 CytoTrack Business Overview
  40. 6.7.3 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  42. 6.7.5 CytoTrack Recent Developments
  43. 6.8 Celsee
  44. 6.8.1 Celsee Company Information
  45. 6.8.2 Celsee Business Overview
  46. 6.8.3 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  48. 6.8.5 Celsee Recent Developments
  49. 6.9 Fluxion
  50. 6.9.1 Fluxion Company Information
  51. 6.9.2 Fluxion Business Overview
  52. 6.9.3 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  54. 6.9.5 Fluxion Recent Developments
  55. 6.10 Gilupi
  56. 6.10.1 Gilupi Company Information
  57. 6.10.2 Gilupi Business Overview
  58. 6.10.3 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  60. 6.10.5 Gilupi Recent Developments
  61. 6.11 Cynvenio
  62. 6.11.1 Cynvenio Company Information
  63. 6.11.2 Cynvenio Business Overview
  64. 6.11.3 Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Cynvenio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  66. 6.11.5 Cynvenio Recent Developments
  67. 6.12 On-chip
  68. 6.12.1 On-chip Company Information
  69. 6.12.2 On-chip Business Overview
  70. 6.12.3 On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 On-chip Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  72. 6.12.5 On-chip Recent Developments
  73. 6.13 YZY Bio
  74. 6.13.1 YZY Bio Company Information
  75. 6.13.2 YZY Bio Business Overview
  76. 6.13.3 YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 YZY Bio Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  78. 6.13.5 YZY Bio Recent Developments
  79. 6.14 BioView
  80. 6.14.1 BioView Company Information
  81. 6.14.2 BioView Business Overview
  82. 6.14.3 BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 BioView Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  84. 6.14.5 BioView Recent Developments
  85. 6.15 Fluidigm
  86. 6.15.1 Fluidigm Company Information
  87. 6.15.2 Fluidigm Business Overview
  88. 6.15.3 Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Fluidigm Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  90. 6.15.5 Fluidigm Recent Developments
  91. 6.16 Ikonisys
  92. 6.16.1 Ikonisys Company Information
  93. 6.16.2 Ikonisys Business Overview
  94. 6.16.3 Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Ikonisys Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  96. 6.16.5 Ikonisys Recent Developments
  97. 6.17 AdnaGen
  98. 6.17.1 AdnaGen Company Information
  99. 6.17.2 AdnaGen Business Overview
  100. 6.17.3 AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 AdnaGen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  102. 6.17.5 AdnaGen Recent Developments
  103. 6.18 IVDiagnostics
  104. 6.18.1 IVDiagnostics Company Information
  105. 6.18.2 IVDiagnostics Business Overview
  106. 6.18.3 IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 IVDiagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  108. 6.18.5 IVDiagnostics Recent Developments
  109. 6.19 Miltenyi Biotec
  110. 6.19.1 Miltenyi Biotec Company Information
  111. 6.19.2 Miltenyi Biotec Business Overview
  112. 6.19.3 Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Miltenyi Biotec Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  114. 6.19.5 Miltenyi Biotec Recent Developments
  115. 6.20 ScreenCell
  116. 6.20.1 ScreenCell Company Information
  117. 6.20.2 ScreenCell Business Overview
  118. 6.20.3 ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 ScreenCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  120. 6.20.5 ScreenCell Recent Developments
  121. 6.21 Silicon Biosystems
  122. 6.21.1 Silicon Biosystems Company Information
  123. 6.21.2 Silicon Biosystems Business Overview
  124. 6.21.3 Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Silicon Biosystems Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Portfolio
  126. 6.21.5 Silicon Biosystems Recent Developments
7 North America
  1. 7.1 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2021-2026)
  3. 7.3 North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2021-2026)
  3. 8.3 Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2021-2026)
  3. 10.3 South America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst